CATX Perspective Therapeutics, Inc.
NEUTRAL
Impact: 2/10
PRESS-RELEASE
Press release: announcement
Latest settled — T+20d
CATX ▼ -11.56% at T+20d
NEUTRAL call ✗ call lost -11.56% · α vs SPY -21.44% · entry $4.41 → $3.90
Last close $2.95 (close Jun 12) · -33.11% from $4.41 entry
T+1d
-0.68%
call -0.68% · α -1.16%
$4.38
settled 2mo ago
T+5d
+1.36%
call +1.36% · α -2.26%
$4.47
settled 2mo ago
T+20d
-11.56%
call -11.56% · α -21.44%
$3.90
settled 6w ago
T+60d
—
call — · α —
—
in 15d
Price Chart
Loading chart...
Executive Summary
Perspective Therapeutics announced upcoming investor presentations at two biopharma conferences in mid-April 2026. The filing is a routine disclosure of management participation in industry events and contains no new financial or clinical data.
Actionable Insight
No trading catalyst is present in this release. Traders should monitor the upcoming presentations for any unexpected updates on clinical data, development timelines, or funding plans.
Key Facts
- Company to present at Needham Virtual Healthcare Conference on April 14, 2026 (9:30-10:10 a.m. ET)
- Participating in one-on-one meetings at Piper Sandler Spring Biopharma Symposium on April 16, 2026 in Boston
- No new clinical, financial, or operational updates provided
- Press release consists solely of forward-looking statements and corporate event logistics
Financial Impact
No immediate financial impact
Risk Factors
- Forward-looking statements are subject to significant risks including clinical trial delays, funding shortfalls, and regulatory setbacks
- Lack of near-term catalysts may contribute to stock volatility ahead of conference appearances
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3267215 |
13 reports for CATX
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
3d ago
|
Institutional Cluster
| $2.96 awaiting T+1 | awaiting T+1 | — | $2.95 (−0.34%) |
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $2.96 awaiting T+1 | awaiting T+1 | — | $2.95 (−0.17%) |
|
Jun 3, 2026
11d ago
|
Press Release
| $3.56 $3.25 | ▼ −8.71% | ▼ −9.11% | $2.95 (−17.13%) |
|
Jun 1, 2026
13d ago
|
8-K
| $3.66 $3.60 | ▼ −1.64% | ▼ −1.78% | $2.95 (−19.40%) |
|
May 21, 2026
24d ago
|
Press Release
| $3.98 $4.16 | ▲ +4.52% | ▲ +3.94% | $2.95 (−25.88%) |
|
May 18, 2026
27d ago
|
Press Release
| $3.76 $3.63 | ▼ −3.46% | ▼ −2.81% | $2.95 (−21.54%) |
|
May 11, 2026
4w ago
|
8-K
| $3.77 $3.77 | · 0.00% | ▼ −0.54% | $2.95 (−21.75%) |
|
May 4, 2026
5w ago
|
8-K
| $3.65 $3.82 | ▲ +4.66% | ▲ +3.27% | $2.95 (−19.18%) |
|
Apr 24, 2026
7w ago
|
Press Release
| $4.51 $4.27 | ▼ −5.32% | ▼ −5.49% | $2.95 (−34.59%) |
|
Apr 20, 2026
7w ago
|
Press Release
| $4.55 $4.64 | ▲ +1.98% | ▲ +2.63% | $2.95 (−35.16%) |
Showing 10 of 13
US Market Status
Market Closed — Opens in 4h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access